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A B S T R A C T
Objective: The Osteoarthritis Quality of Life scale (OAQoL) is an osteoarthritis-speciﬁc measure developed
in the United Kingdom by a needs-based approach. This study describes the adaptation and validation of
this English scale into French.
Methods: The OAQoL was translated into French by a dual-panel technique followed by cognitive
debrieﬁng interviews. Internal consistency was assessed by the Cronbach a. Construct validity was
tested by exploratory and conﬁrmatory factor analyses and by convergent and divergent correlations
with other patient-reported outcome measures by the Spearman rho (r). Reliability was explored by
Spearman rho as well as the Bland and Altman method for the total score and Cohen’s kappa for each
item score.
Results: Cognitive debrieﬁng revealed the French OAQoL to be clear, relevant and comprehensive. The
Cronbach a was 0.91. Exploratory factor analysis extracted 4 groups of items. After eliminating 4 items,
conﬁrmatory factor analysis of the remaining 18 items conﬁrmed higher intra-factor than inter-factor
correlations. The expected convergent and divergent correlations were observed. Test-retest reliability
was good (r 0.93) and was conﬁrmed by Bland and Altman analysis; most items (12/18) had kappa
values from 0.61 to 0.80.
Conclusion: The French OAQoL is an easy-to-use 18-item questionnaire with good content and construct
validity to assess the impact of osteoarthritis on quality of life for French-speaking patients.
 2015 Elsevier Masson SAS. All rights reserved.
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Osteoarthritis (OA) is a frequent disease worldwide with an
important impact on patient disability and quality of life (QOL) [1–
3]. It is the most frequent musculoskeletal disease [4,5] and affects
10% of the global population older than 60 years old [6]. OA has
been ranked the 11th cause of years lived with disability in the
2010 World Health Organization (WHO) global burden of diseases
study [7].
QOL encompasses social, psychological and spiritual well-being
of the person and how these aspects interact with the person’s
environment. The WHO researchers deﬁne QOL as ‘‘the perception
of the individual of their position in life in the context of the culture
and value systems in which they live in relation to their goals,* Corresponding author at: Service de re´e´ducation fonctionnelle de l’appareil
locomoteur et du rachis, CHU Cochin, 27, rue du Faubourg-Saint-Jacques,
75014 Paris, France. Tel.: +33 01 58 41 25 41; fax: +33 01 58 41 25 45.
E-mail addresses: gaelle.couraud2@gmail.com (G. Couraud),
serge.poiraudeau@cch.aphp.fr (S. Poiraudeau).
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1877-0657/ 2015 Elsevier Masson SAS. All rights reserved.expectations, standards and concerns.’’ Consequences of disease
and its treatments on QoL are represented by health-related
quality of life. QoL is also affected by personality, economic status,
education level, environment, liberty, social integration, and
demographics [8] (Fig. 1).
Several patient-reported outcome measures are available for OA
assessment. The most frequently ones focusing on pain and disability
are the Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC) [9], the Lequesne index [10,11] and the Cochin
index [12]. These tools are joint-speciﬁc but do not assess QoL. In
many OA cohorts and trials, QoL is assessed by generic instruments
such as the Medical Outcomes Study 36-Item Short Form [13,14] or
the Nottingham Health Proﬁle (NHP) [15,16], but generic instru-
ments are less sensitive to change than speciﬁc measures [17,18].
We lack qualitative interview studies with patients for selecting
items for patient-reported outcomes most frequently used in OA.
Consequently, there is a gap between what clinicians and patients
deem important. Frequently, clinicians ignore socioeconomic and
psychological issues [19]. For example, they judge the success of
treatment in terms of disability or progression of disease and
Fig. 1. Factors affecting quality of life.
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not necessarily reﬂect patients’ perception of their QoL [20,21].
The needs-based approach was developed to devise QoL tools
based on the holistic approach rather than treatments and disease;
one such tool isthe OA knee and hip QoL questionnaire (OAQKQOL)
[22], developed for knee and hip based on the classiﬁcation of
functioning disability and health [23]. Needs-based measures
include only items that are generated directly from patients. These
items are collected during interviews and are not deﬁned by the
medical disability model [24,25]. Needs-based QoL instruments
have been found useful in determining the beneﬁts of interventions
(from the patient perspective) in clinical trials. In plain language,
this method is based on a validated development technique
involving in-depth qualitative interviews with relevant patients.
The focus of this approach is to derive an outcome measure based on
issues that are important to the person with the disease and not
deﬁned by the medical disability model, which is the focus of
health-related QoL instruments. A few needs-based QoL tools were
developed in medicine (dermatology, psychiatry, neurology)
[26]. Recently, the OA Quality of Life scale (OAQoL) [27] was
developed in the United Kingdom by the approach and validated for
use in upper limb, lower limb and multiple-site OA. The English
OAQoL is a simple 22-item one-dimensional questionnaire with
good psychometric properties. It gives a simple summary score for
the overall impact of OA on the ability of patients to meet their
needs and is clearly differentiated from health status.
The aim of this study was to translate the English OAQoL into
French and test the validity and reliability of the French version.
2. Patients and methods
The initial development of the OAQoL determined protocols for
adaptation, validation and analysis of the instrument in 6 different
European languages (French, German, Hungarian, Italian, Spanish
and Turkish). This study focused on the adaptation and validation
of the OAQoL in the French language.
3. Translation of questionnaire
A conceptual translation rather than a literal translation was
used, and the ﬁnal version had to be easy to understand. The
methodology was the dual-panel technique and included the
following steps [28–30].
First, a bilingual panel, composed of 5 members born in France
and speaking ﬂuent English produced a ﬁrst version of OAQoL inFrench. Then, a second panel, managed by the same moderator and
composed of 5 members of French nationality, worked with the
French version only. This user panel discussed every item, made
modiﬁcations and selected the appropriate bilingual panel’s
proposition for each item. A second version of French OAQoL
was produced. Then, an expert committee meeting was organized
to select a pre-ﬁnal translated version.
The pre-ﬁnal translated version was tested during a cognitive
debrieﬁng exercise with 20 OA patients. Inclusion criteria were
patients with hip, hand, knee and foot OA. Diagnosis of hip, hand
and knee OA was based on the American College of Rheumatology
criteria [31,32]. For foot OA, in the absence of any OA diagnostic
criteria, patients were included if they had symptomatic, clinically
diagnosed OA conﬁrmed by radiography. Patients were excluded if
they did not speak and read French ﬂuently, had signiﬁcant
comorbidity or had surgery for joint prosthesis in the last
6 months. Each patient completed the questionnaire and then
was interviewed by an expert about the relevance, acceptability,
understanding and clarity of the questionnaire in general and
asked about speciﬁc items that the interviewer had identiﬁed as
potentially problematic. After analysis of international cognitive
debrieﬁng results, the expert committee met to ﬁnalize the French
version of the OAQoL.
4. Validation of questionnaire
The French version of OAQoL was tested in a cohort of OA
patients to verify its validity and reliability. Inclusion and
exclusion criteria were the same as for the debrieﬁng interview
steps.
A survey package was mailed to patients in primary and
secondary care. Consensus is lacking on the sample size for this
kind of study [33,34]. The package included questions on
demographic and disease items (age, sex, education level, site of
OA, duration of OA symptoms) as well as several questionnaires.
The questionnaires included the OAQoL, a numeric scale for pain
(0 to 10), a Likert scale of OA severity (self-assessment by patients
in 3 classes), the NHP questionnaire (to measure perceived well-
being), the Cochin scale (to assess disability for hand OA) and the
WOMAC (to assess pain and disability for lower limb OA). Baseline
OAQoL was used to assess internal construct validity. The ﬁrst
80 patients completed the questionnaires again 2 weeks after
baseline, and these data were used for test-retest reliability.
5. Statistical analysis
We used descriptive statistics to examine the response
distribution of each item.
Internal consistency of the instrument was assessed by the
Cronbach a to examine the degree to which items in a scale
measured the same concept [35]; a Cronbach a > 0.70 was
considered acceptable, 0.71–0.80 respectable and > 0.80 very good
[36].
Construct validity was assessed by exploratory and conﬁrma-
tory factor analysis and divergent and convergent correlations
[37]. Exploratory factor analysis with unweighted least-squares
factor analysis (ULS) was used to identify complex interrelations-
hips among items and group items that are part of uniﬁed
concepts. We extracted factors (groups of items) generated by ULS
with corresponding eigenvalues > 1 according to Kaiser’s rule
(attesting to the signiﬁcance of the ULS). In the case of multiple
loading of an item on several factors, the item was included in the
factor with a better conceptual relationship. Conﬁrmatory factor
analysis (with linear equation method) tested the hypothesis that
items were associated with speciﬁc factors and to conﬁrm
exploratory factor analyses. A model was retained if the following
Table 1
Baseline characteristics of 119 patients with osteoarthritis (OA) who tested the
French OA Quality of Life (OAQoL) scale.
Age (years), mean  SD 70.2  11.1
Sex, women, n (%) 87 (73.7)
Disease duration (years), mean  SD 13.6  12.1
Severity of OA, n (%)
Mild 14 (11.9)
Moderate 66 (55.9)
Very severe 38 (32.2)
Working, n (%)
Full time 15 (13.2)
Part time 1 (0.9)
Retired 92 (80.7)
Long-term disability 2 (1.7)
Unemployed 4 (3.5)
Site of OA, n (%)
Hip 23 (19.5)
Knee 90 (76)
Ankle 6 (5.1)
Foot 18 (15.2)
Lower back 35 (29.7)
Upper Back 16 (13.5)
Neck 32 (27.1)
Shoulder 24 (20.3)
Elbow 4 (2.2)
Wrist 12 (10.2)
Hand 44 (24.4)
Thumb 10 (8.5%)
Questionnaire scores, mean  SD
OAQoL total 9.3  6.4
WOMAC total 39.4  19.7
Nottingham Health Proﬁle total 206.9  125.5
Cochin total 17.1  16.4
Pain (0–10) 5.7  2.1
WOMAC: Western Ontarion and McMaster Universities Osteoarthritis Index.
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approximation (RMSEA) < 0.06 and comparative ﬁt index (CFI),
normed ﬁt index (NFI) and non-normed ﬁt index (NNFI) > 0.9. For
convergent and divergent correlations, we hypothesized that the
French OAQoL global score would be more closely correlated with
the NHP score (measuring well-being) than with scores from scales
measuring function or pain. Correlation between scores was tested
by Spearman’s rho (r). Correlation was very good with r = 1.00–
0.91, good with r = 0.90–0.81, moderate with r = 0.80–0.71, slight
with r = 0.7–0.51 and very slight with r = 0.50–0.00 [38,39].
Test-retest reliability was assessed by Spearman’s rho and the
Bland and Altman method [40] for total scores; for each item score,
it was assessed by the Cohen kappa (k < 0 indicating no agreement
and k = 0–0.20 slight, k = 0.21–0.40 fair, k = 0.41–0.60 moderate,
k = 0.61–0.80 substantial and k = 0.81–1.0 perfect agreement) [41].
The data were analyzed by use of SAS 9.3.
Ethical approval was received from the Comite´ d’e´valuation
clinique de l’Inserm.
6. Results
6.1. Translation and debrieﬁng interviews
After bilingual panel translation, a pre-ﬁnal version of the
OAQoL questionnaire was constructed. Patients interviewed about
this version were from 36 to 91 years old (mean age
70.2  11.1 years), with mean disease duration 13.4  7.97 years;
patients were predominantly women (16/20). From the patient
responses, the expert committee found the French version to be clear,
unambiguous, comprehensive and easy to complete (Appendix 1).
Four items were slightly changed on the basis of respondents’
comments. The ﬁrst item, ‘‘I get embarrassed using stairs in public (Je
suis geˆne´ quand j’utilise les escaliers en public),’’ was changed to ‘‘I
am ashamed when I use stairs in public (J’ai honte quand j’utilise les
escaliers en public)’’ because it was more comprehensive. The French
term for embarrassed means whether having physical or psychologi-
cal difﬁculties. The second item, ‘‘It interferes with everything that I
do (L’arthrose me geˆne dans tout ce que je fais),’’ was changed to
‘‘Osteoarthritis bothers me in almost all my activities (L’arthrose me
geˆne dans la plupart de mes activite´s)’’ because many patients
answered ‘‘false’’ even if they had difﬁculties in almost all activities;
therefore, the question was modiﬁed with ‘‘most’’ instead of ‘‘all’’
activities. The third item, ‘‘Osteoarthritis controls my life (L’arthrose
controˆle ma vie),’’ was changed to ‘‘Osteoarthritis conditions my life
(L’arthrose conditionne ma vie)’’ because in French, the term
‘‘condition’’ is more comprehensive and less abstract than ‘‘control’’.
The fourth item, ‘‘I can’t go to the places I want to go (Je ne peux pas
aller ou` je veux),’’ was changed to ‘‘I cannot go everywhere I want to
go (Je ne peux pas aller partout ou` je veux)’’ because it was more clear
for patients.
6.2. Validation of the questionnaire
6.2.1. Patients
The survey package was mailed to 150 patients in primary and
secondary care because we aimed to analyse 120 questionnaires
and estimated a response rate of 80%. At baseline, 119 (75.3%) of
the 150 questionnaires were returned. No respondents were
excluded. A total of 80 questionnaires were returned at 2 weeks
and analysed for test-retest reliability.
The mean age of respondents was 70.2  11.1 years and mean
symptom duration 13.6  12.1 years (median 10 years, interquartile
range 5–19.5) Most respondents were women (73.7%); 80.7% were
retired (Table 1).
Data were missing for 2.7% of respondents at baseline and 4.8%
at follow-up. These questionnaires were not analyzed.6.2.2. Internal consistency of the total score
The Cronbach a was 0.93 [95% CI 0.89–0.95]. The Cronbach a for
each item and correlation with the total score are in Table 2.
6.2.3. Construct validity
Exploratory factor analysis extracted 4 main factors with
eigenvalues of 10.50, 2.37, 1.35 and 1.12 explaining 0.70 of the
variance (Fig. 2). Each group was easily characterised: group 1
(8 items) represented psychological impact and social isolation;
group 2 (8 items), decreased autonomy; group 3 (3 items),
importance granted to the disease; and group 4 (3 items), walking
disability. Correlations for each item in each factor are in Table 3.
Conﬁrmatory multi-trait analyses conﬁrmed higher intra-factor
than inter-factor correlation (Fig. 3) but revealed that 4 items
(items 1, 2, 10 and 22) needed to be eliminated to obtain well-
deﬁned distinct groups. The model with 22 items was not
satisfactory because Chi2 (0.0001), RMSEA (0.0672) and NFI
(0.07818) values did not meet the threshold cutoff. The model
with 18 items was statistically better because only the chi-square
value (0.0098) was less than the cutoff value and the NFI value
(0.8387) was greater than the cutoff. The RMSEA was good (0.0563)
(Table 4) (Appendix 2).
Convergent and divergent correlations were as expected. The
French OAQoL score best correlated with the NHP than WOMAC,
pain, and Cochin hand scale scores (Table 5).
6.2.4. Internal consistency of each factor
The reliability of each factor was good: the Cronbach a for factor
1 was 0.87 (95% CI 0.85–0.90); factor 2, 0.86 (0.83–0.92); factor 3,
0.76 (0.72–0.80); and factor 4, 0.77 (0.74–0.80).
Table 2
Cronbach a for each item of the French OAQoL scale and correlation with total score.
Item Cronbach a Correlation with total score
Item 1 0.930723 0.642591
Item 2 0.934988 0.361701
Item 3 0.932393 0.551264
Item 4 0.930480 0.656384
Item 5 0.930020 0.688210
Item 6 0.929744 0.697042
Item 7 0.930557 0.653685
Item 8 0.931794 0.581552
Item 9 0.932504 0.544824
Item 10 0.932743 0.515843
Item 11 0.932335 0.550705
Item 12 0.930155 0.680671
Item 13 0.929988 0.682788
Item 14 0.930885 0.636484
Item 15 0.929533 0.708098
Item 16 0.933175 0.506592
Item 17 0.931006 0.626259
Item 18 0.933295 0.482593
Item 19 0.929399 0.714693
Item 20 0.930917 0.631742
Item 21 0.932481 0.534114
Item 22 0.930529 0.653361
Table 3
Correlations among items in each factor of the OAQoL scale.
Item Factor 1 Factor 2 Factor 3 Factor 4
Item 11 0.76389a 0.37529 0.37397 0.37367
Item 18 0.64299a 0.31396 0.27346 0.23500
Item 4 0.72388a 0.49266 0.50256 0.48101
Item 12 0.73274a 0.49893 0.61708 0.37190
Item 14 0.71968a 0.51313 0.57538 0.38626
Item 7 0.66959a 0.43643 0.54441 0.53274
Item 5 0.67265a 0.55990 0.57439 0.37606
Item 10 0.56115a 0.47661 0.32459 0.33485
Item 21 0.35221 0.65808a 0.35370 0.33967
Item 15 0.58295 0.74018a 0.43842 0.45761
Item 3 0.40065 0.67889a 0.56810 0.25569
Item 20 0.45825 0.72101a 0.42762 0.54262
Item 17 0.38590 0.64789a 0.51983 0.39601
Item 19 0.52459 0.72994a 0.59441 0.51247
Item 8 0.36515 0.65436a 0.64395 0.36445
Item 2 0.42246 0.50162a 0.15928 0.34163
Item 13 0.54440 0.51467 0.83746a 0.43109
Item 16 0.33352 0.31761 0.62747a 0.35961
Item 1 0.52811 0.52793 0.68742a 0.56095
Item 9 0.39008 0.40752 0.42835 0.88561a
Item 6 0.50263 0.62344 0.50395 0.79635a
Item 22 0.48612 0.59802 0.45269 0.67097a
a Highest correlation coefﬁcient for each item for a factor.
Table 4
Conﬁrmatory factor analysis of the French OAQoL scale.
Criteria 22-item
model
18-item
model
Fulﬁlled
criteria
2
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The test-retest reliability for the OAQoL global score was
excellent; the Spearman r was 0.93 (P < 0.0001). The Bland and
Altman graphic method conﬁrmed this result (Fig. 4). Kappa values
for most items (12/18) were compatible with substantial
aggrement and for 5 items were compatible with perfect
agreement; only one item had a k-value compatible with moderate
agreement (Table 6).
7. Discussion
In this study, we developed an 18-item French version of the
OAQoL. To our knowledge, this is the ﬁrst needs-based instrument
available in French to assess QoL in OA. The panel method of
translation allowed for developing the French scale in a language
understandable to patients and not in a ‘‘medical language’’. This
questionnaire is easy to complete and understand and is
acceptable. Its validity and reliability are substantial.Fig. 2. Exploratory factor analysis of the French OAQoL scale.Functional impairment and pain due to OA have been reported
extensively in the literature, but the affective and psychological
impact of OA has been much less assessed [10–12,22]. The needs-
based approach allows for assessing aspects of these difﬁculties in
patients’ lives. Therefore, the original English version of the OAQoL
not unsurprisingly included items related to decreased autonomy,
psychological impact, importance granted to the disease, func-
tional disability, the unexpected nature of OA, and social isolation.
After construct validity testing, an 18-item questionnaire in
French was more appropriate than the original 22-item version.
The factorial structure was robust, with 4 factors identiﬁed andTable 5
Correlation between French OAQoL score and scores for other outcome measures.
Other outcome measures Spearman r P-value
WOMAC total score
All patients 0.71 < 0.0001
Hip and knee OA patients 0.71 < 0.0001
Nottingham Health Proﬁle 0.79 < 0.0001
Cochin scale
All patients 0.3 0.0135
Hand OA patients 0.38 0.0108
Pain (0–10) 0.53 < 0.0001
Likert scale of OA severity 0.54 < 0.0001
OAQoL total score at follow-up 0.94 < 0.0001
WOMAC: Western Ontarion and McMaster Universities Osteoarthritis Index.
Chi 0.0001 0.0098 > 0.05
Root mean square error
approximation
0.0672 0.0563 < 0.06
Comparative ﬁt index 0.9211 0.9955 > 0.9
Normed ﬁt index 0.7818 0.8387 > 0.9
Non-normed ﬁt index 0.9061 0.9466 > 0.9
Fig. 3. Conﬁrmatory multi-trait analyses of the French OAQoL scale.
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were conﬁrmed by conﬁrmatory factor analysis.
The metric properties of this French version of the OAQoL are
promising and are much closer to those reported for the English
version, which suggests that the translation did not change the
comprehensiveness and that both scales measure the same
concepts. In the English study, the person separation index from
the Rash model was used rather than the Cronbach a but with the
same interpretation. The English OAQoL scale also demonstrated
signiﬁcant moderate correlation with pain and stiffness domains of
the WOMAC (r = 0.67 and r = 0.71, respectively) and good
correlation with the WOMAC disability domain (r = 0.80). We
found weak correlation between the OAQoL and Cochin score
(r = 0.49) but moderate correlation with a general well-beingFig. 4. Bland and Altman assessment of reliabiindex, the NHP (r = 0.68). For test-retest reliability, the correla-
tion between times 1 and 2 was excellent (r = 0.93) and the k-
value for each item ranged from moderate (k = 0.5817) to excellent
(k = 0.8534).
However, several limitations of this study should be noted.
First, we cannot exclude a selection bias. Only 119 of the
150 questionnaires sent were completed at time 1. We excluded
incomplete questionnaires from the analysis and we cannot
exclude that some patients who did not complete questionnaires
may have had difﬁculties understanding the concept of the OAQoL
and items of other questionnaires. Another limitation is that the
study protocol did not allow for deﬁning a threshold to classify
patients in disease-severity categories by impact of OA on their
QoL, for unsure interpretation of the OAQoL scale score. The thirdlity of the French OAQoL scale total score.
Table 6
Cohen kappa values for each item of the French OAQoL
scale.
Item Kappa
OA 3 0.6604 [0.4874–0.8334]
OA 4 0.6753 [0.4910–0.8596]
OA 5 0.7015 [0.4959–0.9071]
OA 6 0.7656 [0.6218–0.9095]
OA 7 0.8145 [0.6582–0.9707]
OA 8 0.6705 [0.5009–0.8401]
OA 9 0.8402 [0.7183–0.9621]
OA 11 0.5817 [0.2811–0.8822]
OA 12 0.7308 [0.5455–0.9161]
OA 13 0.6774 [0.5105–0.8444]
OA 14 0.6531 [0.4322–0.8741]
OA 15 0.7002 [0.5366–0.8638]
OA 16 0.6434 [0.4679–0.8188]
OA 17 0.7120 [0.5544–0.8697]
OA 18 0.7475 [0.4742–1.0000]
OA 19 0.8111 [0.6784–0.9438]
OA 20 0.8534 [0.7294–0.9775]
OA 21 0.8403 [0.7066–0.9740]
Appendix 1. Instructions and 22 items of the OAQoL
questionnaire
Apre`s avoir lu chaque afﬁrmation attentivement, merci de cocher la case
correspondant a` la re´ponse qui s’applique le mieux a` vous en ce moment.
1. L’arthrose m’empeˆche de participer aux activite´s
de mes amis ou de ma famille
Vrai &/Faux &
2. J’ai honte quand j’utilise les escaliers en public Vrai &/Faux &
3. J’ai l’impression qu’une partie de ma vie m’e´chappe Vrai &/Faux &
4. Je ne peux rien pre´voir a` l’avance Vrai &/Faux &
5. J’ai l’impression d’eˆtre coince´ chez moi Vrai &/Faux &
6. L’athrose limite mes de´placements Vrai &/Faux &
7. Je ne peux rien faire a` l’improviste Vrai &/Faux &
8. L’arthrose me geˆne dans la plupart de mes activite´s Vrai &/Faux &
9. Marcher pour le plaisir n’est pas envisageable Vrai &/Faux &
10. Je n’ai plus aucun plaisir a` sortir Vrai &/Faux &
11. Je me sens inutiles Vrai &/Faux &
12. J’ai l’impression de ne pas pouvoir participer
a` la vie sociale
Vrai &/Faux &
13. L’athrose conditionne ma vie Vrai &/Faux &
14. Je me sens de´pendant(e) des autres Vrai &/Faux &
15 J’ai peur d’eˆtre une charge pour les autres Vrai &/Faux &
16. Ma vie doit s’organiser autour de l’arthrose Vrai &/Faux &
17. Je ne suis pas aussi autonomne que je le voudrais Vrai &/Faux &
18. Je me sens tre`s isole´(e) Vrai &/Faux &
19. Je ne peux pas proﬁter pleinement de la vie Vrai &/Faux &
20. Je dois limiter mes activite´s quotidiennes Vrai &/Faux &
21. Je me sens ralenti(e) Vrai &/Faux &
22. Je ne peux pas aller partout Vrai &/Faux &
Appendix 2. 18 items of the OAQoL scale
Group 1: Psychological impact and social isolation
Item 4 Je ne peux rien pre´voir a` l’avance
Item 5 J’ai l’impression d’eˆtre coince´(e) chez moi
Item 7 Je ne peux rien faire a` l’improviste
Item 11 Je me sens inutile
Item 12 J’ai l’impression de ne pas pouvoir participer a` la vie sociale
Item 14 Je me sens de´pendant(e) des autres
Item 18 Je me sens tre`s isole´(e)
Group 2: Decreased autonomy
Item 3 J’ai l’impression qu’une partie de ma vie m’e´chappe
Item 8 L’arthrose me geˆne dans la plupart de mes activite´s
Item 15 J’ai peur d’eˆtre une charge pour les autres
Item 17 Je ne suis plus aussi autonome que je le voudrais
Item 19 Je ne peux pas proﬁter pleinement de la vie
Item 20 Je dois limiter mes activite´s quotidiennes
Item 21 Je me sens ralenti(e)
Group 3: Importance granted to the disease
Item 13 L’arthrose conditionne ma vie
Item 16 Ma vie doit s’organiser autour de l’arthrose
Group 4 Functional disability
Item 6 L’arthrose limite mes de´placements
Item 9 Marcher pour le plaisir n’est pas envisageable
G. Couraud et al. / Annals of Physical and Rehabilitation Medicine 58 (2015) 336–342 341limitation is the lack of information about treatment modiﬁcations
between times 1 and 2, so we cannot know whether differences in
score results are due to modifying treatment. Furthermore, we did
not assess sensivity to change.
In conclusion, the 18-item French OAQoL is a brief question-
naire, easy to use and practical to administer in daily practice
because patients can complete it by themselves. The French OAQoL
scale is a unidimensional measure with good internal consistency:
18 items are representative of a random sample from a larger
universe of items. Therefore, it is an OA-speciﬁc instrument valid
for use for upper and lower limb and generalized OA. The
usefulness of this questionnaire should now be tested in larger
cohorts. Especially, responsiveness should be assessed and
validation of thresholds is needed for easier interpretation.
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